LifeMD Reschedules Third Quarter Earnings Announcement
LifeMD, Inc. (NASDAQ: LFMD), a pioneer in virtual healthcare services, recently made an important announcement regarding its third quarter 2025 earnings release. The company has officially rescheduled the release and its associated conference call to Monday, November 17, 2025. This strategic alteration comes as the company engages with the U.S. Securities and Exchange Commission (SEC) to notify them via a Form 12b-25 regarding a late filing of its Form 10-Q for the period ending September 30, 2025.
The Reason Behind the Rescheduling
The decision to defer the earnings announcement stems from the identification of specific corrections related to revenue recognition and corresponding balance sheet accounts. These errors, dating back to the twelve months ending in December 2023 and December 2024, as well as the six months to June 30, 2025, were notable. LifeMD has estimated that these necessary adjustments will impact cumulative revenue by approximately $4.6 million, equating to around 1.4% of the cumulative revenue reported in the prior periods. The management team has assured stakeholders that these adjustments will not materially alter the overall revenue guidance during these reporting periods, nor will they affect the company’s cash flow or financial positioning.
Details of the Earnings Release and Conference Call
LifeMD is poised to issue its earnings press release on or around 4:05 p.m. Eastern Time on November 17, followed closely by the conference call at 4:30 p.m. Eastern Time. Investors and interested parties can join the conversation using the details below:
Conference Call Details:
- Date: Monday, November 17
- Time: 4:30 p.m. Eastern time
- Toll-Free Dial-In: 800-245-3047
- International Dial-In: 203-518-9765
- Conference ID: LIFEMD
- Live & Archived Webcast: Available online
About LifeMD, Inc.
LifeMD, Inc. has positioned itself as a frontrunner in virtual primary care, offering telemedicine solutions and comprehensive healthcare services. Their expertise spans over 200 conditions including primary care, mental health, and more. The company operates with an integrated digital care platform paired with a state-of-the-art pharmacy and a nationwide medical group, effectively increasing access to high-quality and affordable healthcare solutions for all patients.
Commitment to Transparency and Communication
In an ever-evolving healthcare landscape, LifeMD is dedicated to maintaining transparent communication with its investors and the public. The adjustments leading to this rescheduled earnings conference indicate a serious commitment to accuracy in financial reporting. Management remains vigilant in ensuring that all necessary changes are implemented without adversely affecting their operations or financial results.
Investor Relations
For inquiries regarding investor relations, please contact:
Marc Benathen, Chief Financial Officer
marc@lifemd.com
Media Inquiries
Jessica Friedeman, Chief Marketing and Product Officer
press@lifemd.com
Frequently Asked Questions
What date is LifeMD's third quarter earnings call?
The call is scheduled for November 17, 2025, at 4:30 p.m. Eastern time.
Why was the earnings announcement rescheduled?
The rescheduling is due to the identification of accounting errors related to revenue recognition.
How much will the adjustments affect reported revenue?
The adjustments will impact reported revenue by approximately $4.6 million.
Will these adjustments affect LifeMD's cash flow?
No, the required adjustments will not influence the company's cash flow or cash position.
Where can I find more information about LifeMD?
More information can be found on the official LifeMD website.
